US 11,744,499 B2
Monitoring bladder dysfunction using a probability function
Dwight E. Nelson, Shoreview, MN (US); Thaddeus S. Brink, St. Paul, MN (US); Lance Zirpel, Lino Lakes, MN (US); and Adam P. Steiner, Mankato, MN (US)
Assigned to Medtronic, Inc., Minneapolis, MN (US)
Filed by Medtronic, Inc., Minneapolis, MN (US)
Filed on Sep. 1, 2020, as Appl. No. 17/9,525.
Application 17/009,525 is a continuation of application No. 15/964,739, filed on Apr. 27, 2018, granted, now 10,765,355.
Prior Publication US 2020/0397361 A1, Dec. 24, 2020
Int. Cl. A61B 5/20 (2006.01); A61N 1/36 (2006.01); G16H 20/40 (2018.01); G16H 50/30 (2018.01); A61B 5/00 (2006.01); A61B 5/391 (2021.01)
CPC A61B 5/204 (2013.01) [A61B 5/205 (2013.01); A61N 1/36007 (2013.01); A61B 5/391 (2021.01); A61B 5/4836 (2013.01); G16H 20/40 (2018.01); G16H 50/30 (2018.01)] 20 Claims
OG exemplary drawing
 
1. A system comprising:
processing circuitry configured to:
determine a first probability to void function indicative of first probabilities, as a variable function over a first period of time, to experience a bladder related event function over the first period of time for a patient;
determine a second probability to void function indicative of second probabilities, as a variable function over a second period of time, to experience the bladder related event function over the second period of time for the patient, the second period of time occurring after the first period of time;
determine a change from the first probability to void function to the second probability to void function;
modify, based on the change, one or more parameters that at least partially define a therapy; and
control delivery of the therapy to the patient according to the modified one or more parameters.